A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

NCT07486102 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Hepatic Impairment

Interventions

DRUG: BI 3000202

Sponsor

Boehringer Ingelheim